Development of human tumor cell line panels for use in disease-oriented drug screening - PubMed (original) (raw)
Affiliations
- PMID: 3051021
Review
Development of human tumor cell line panels for use in disease-oriented drug screening
R H Shoemaker et al. Prog Clin Biol Res. 1988.
No abstract available
Similar articles
- [Results of the evaluation of anti-cancer agents by using human cancer cell panels: details of interpretation].
Yamori T. Yamori T. Gan To Kagaku Ryoho. 2000 Mar;27(1 Suppl):159-80. Gan To Kagaku Ryoho. 2000. PMID: 10780177 Japanese. No abstract available. - Pattern of antitumor activity of a novel camptothecin, ST1481, in a large panel of human tumor xenografts.
Pratesi G, De Cesare M, Carenini N, Perego P, Righetti SC, Cucco C, Merlini L, Pisano C, Penco S, Carminati P, Vesci L, Zunino F. Pratesi G, et al. Clin Cancer Res. 2002 Dec;8(12):3904-9. Clin Cancer Res. 2002. PMID: 12473606 - Drug and radiation sensitivity testing of primary human tumor cells using the adhesive-tumor-cell culture system (ATCCS).
Baker FL, Spitzer G, Ajani JA, Brock WA. Baker FL, et al. Prog Clin Biol Res. 1988;276:105-17. Prog Clin Biol Res. 1988. PMID: 3174675 - Predictive tests for cancer chemotherapy and the problem of tumor cell heterogeneity.
Rustum YM, Slocum HK. Rustum YM, et al. Prog Clin Biol Res. 1988;276:119-37. Prog Clin Biol Res. 1988. PMID: 3051019 Review. No abstract available. - In vitro assays of chemotherapeutic sensitivity.
Carney DN, Winkler CF. Carney DN, et al. Important Adv Oncol. 1985:78-103. Important Adv Oncol. 1985. PMID: 3916747 Review.
Cited by
- Development of a Drug-Response Modeling Framework to Identify Cell Line Derived Translational Biomarkers That Can Predict Treatment Outcome to Erlotinib or Sorafenib.
Li B, Shin H, Gulbekyan G, Pustovalova O, Nikolsky Y, Hope A, Bessarabova M, Schu M, Kolpakova-Hart E, Merberg D, Dorner A, Trepicchio WL. Li B, et al. PLoS One. 2015 Jun 24;10(6):e0130700. doi: 10.1371/journal.pone.0130700. eCollection 2015. PLoS One. 2015. PMID: 26107615 Free PMC article. - Expression of microRNAs in the NCI-60 cancer cell-lines.
Patnaik SK, Dahlgaard J, Mazin W, Kannisto E, Jensen T, Knudsen S, Yendamuri S. Patnaik SK, et al. PLoS One. 2012;7(11):e49918. doi: 10.1371/journal.pone.0049918. Epub 2012 Nov 28. PLoS One. 2012. PMID: 23209617 Free PMC article. - Animal models of human colorectal cancer: Current status, uses and limitations.
Mittal VK, Bhullar JS, Jayant K. Mittal VK, et al. World J Gastroenterol. 2015 Nov 7;21(41):11854-61. doi: 10.3748/wjg.v21.i41.11854. World J Gastroenterol. 2015. PMID: 26557009 Free PMC article. - Appropriateness of using patient-derived xenograft models for pharmacologic evaluation of novel therapies for esophageal/gastro-esophageal junction cancers.
Dodbiba L, Teichman J, Fleet A, Thai H, Starmans MH, Navab R, Chen Z, Girgis H, Eng L, Espin-Garcia O, Shen X, Bandarchi B, Schwock J, Tsao MS, El-Zimaity H, Der SD, Xu W, Bristow RG, Darling GE, Boutros PC, Ailles LE, Liu G. Dodbiba L, et al. PLoS One. 2015 Mar 31;10(3):e0121872. doi: 10.1371/journal.pone.0121872. eCollection 2015. PLoS One. 2015. PMID: 25826681 Free PMC article. - Differential regulation and synthetic lethality of exclusive RB1 and CDKN2A mutations in lung cancer.
Kim N, Song M, Kim S, Seo Y, Kim Y, Yoon S. Kim N, et al. Int J Oncol. 2016 Jan;48(1):367-75. doi: 10.3892/ijo.2015.3262. Epub 2015 Nov 20. Int J Oncol. 2016. PMID: 26647789 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources